A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species

Acute myeloid leukemia (AML) is a heterogeneous and fatal disease with an urgent need for improved therapeutic regimens given that most patients die from relapsed disease. Irrespective of mutation status, the development of aggressive leukemias is enabled by increasing dependence on signaling networ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Hongliang, Gozman, Alexander, Caldas-Lopes, Eloisi, Taldone, Tony, Sturgill, Eric, Brennan, Sarah, Ochiana, Stefan O., Gomes-DaGama, Erica M., Sen, Siddhartha, Rodina, Anna, Koren, John, Becker, Michael W., Rudin, Charles M., Melnick, Ari, Levine, Ross L., Roboz, Gail J., Nimer, Stephen D., Chiosis, Gabriela, Guzman, Monica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699804/
https://www.ncbi.nlm.nih.gov/pubmed/26628369
http://dx.doi.org/10.1016/j.celrep.2015.10.073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699804/
https://www.ncbi.nlm.nih.gov/pubmed/26628369
http://dx.doi.org/10.1016/j.celrep.2015.10.073

Ejemplares similares